Found: 95
Select item for more details and to access through your institution.
Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker.
- Published in:
- Clinical Autonomic Research, 2024, v. 34, n. 3, p. 341, doi. 10.1007/s10286-024-01038-z
- By:
- Publication type:
- Article
Degradation versus fibrillogenesis, two alternative pathways modulated by seeds and glycosaminoglycans.
- Published in:
- Protein Science: A Publication of the Protein Society, 2024, v. 33, n. 3, p. 1, doi. 10.1002/pro.4931
- By:
- Publication type:
- Article
Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac Amyloidosis.
- Published in:
- Journal of the American Heart Association, 2024, v. 13, n. 4, p. 1, doi. 10.1161/JAHA.123.033094
- By:
- Publication type:
- Article
Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin‐mediated amyloidosis with polyneuropathy.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 2, p. 397, doi. 10.1002/ejhf.3138
- By:
- Publication type:
- Article
Extending the reach of expert amyloidosis care: A feasibility study exploring the staged implementation of a UK amyloidosis network.
- Published in:
- Clinical Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1016/j.clinme.2023.100004
- By:
- Publication type:
- Article
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importance.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 1, p. 65, doi. 10.1002/ejhf.3094
- By:
- Publication type:
- Article
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy.
- Published in:
- Neurology & Therapy, 2023, v. 12, n. 5, p. 1759, doi. 10.1007/s40120-023-00522-4
- By:
- Publication type:
- Article
British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of cardiac amyloidosis.
- Published in:
- Echo Research & Practice, 2023, v. 10, n. 1, p. 1, doi. 10.1186/s44156-023-00028-7
- By:
- Publication type:
- Article
Peripheral neuropathy secondary to a 'domino' liver transplant: a case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Prevalence, characteristics and outcomes of older patients with hereditary versus wild‐type transthyretin amyloid cardiomyopathy.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 515, doi. 10.1002/ejhf.2776
- By:
- Publication type:
- Article
RNA Targeting and Gene Editing Strategies for Transthyretin Amyloidosis.
- Published in:
- BioDrugs, 2023, v. 37, n. 2, p. 127, doi. 10.1007/s40259-023-00577-7
- By:
- Publication type:
- Article
The Protein Network in Subcutaneous Fat Biopsies from Patients with AL Amyloidosis: More Than Diagnosis?
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 5, p. 699, doi. 10.3390/cells12050699
- By:
- Publication type:
- Article
Comparison of different technetium-99m-labelled bone tracers for imaging cardiac amyloidosis.
- Published in:
- European Journal of Preventive Cardiology, 2023, v. 30, n. 3, p. e4, doi. 10.1093/eurjpc/zwac237
- By:
- Publication type:
- Article
Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.
- Published in:
- Neurology & Therapy, 2023, v. 12, n. 1, p. 267, doi. 10.1007/s40120-022-00414-z
- By:
- Publication type:
- Article
Treatment of acquired transthyretin amyloidosis in domino liver transplantation.
- Published in:
- Clinical Transplantation, 2023, v. 37, n. 1, p. 1, doi. 10.1111/ctr.14822
- By:
- Publication type:
- Article
Patisiran for the Treatment of Transthyretin-mediated Amyloidosis with Cardiomyopathy.
- Published in:
- Heart International, 2023, v. 17, n. 1, p. 27, doi. 10.17925/HI.2023.17.1.27
- By:
- Publication type:
- Article
Transthyretin cardiac amyloidosis.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 18, p. 3517, doi. 10.1093/cvr/cvac119
- By:
- Publication type:
- Article
Long‐term outcomes in light chain deposition disease‐analysis of a UK cohort.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. E444, doi. 10.1002/ajh.26725
- By:
- Publication type:
- Article
Liver‐directed drugs for transthyretin‐mediated amyloidosis.
- Published in:
- Journal of the Peripheral Nervous System, 2022, v. 27, n. 4, p. 228, doi. 10.1111/jns.12519
- By:
- Publication type:
- Article
Imaging-Guided Treatment for Cardiac Amyloidosis.
- Published in:
- Current Cardiology Reports, 2022, v. 24, n. 7, p. 839, doi. 10.1007/s11886-022-01703-7
- By:
- Publication type:
- Article
Clinical and Genetic Evaluation of People with or at Risk of Hereditary ATTR Amyloidosis: An Expert Opinion and Consensus on Best Practice in Ireland and the UK.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis.
- Published in:
- European Heart Journal, 2022, v. 43, n. 4, p. 333, doi. 10.1093/eurheartj/ehab507
- By:
- Publication type:
- Article
Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27416-z
- By:
- Publication type:
- Article
99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2021, v. 22, n. 11, p. 1304, doi. 10.1093/ehjci/jeab095
- By:
- Publication type:
- Article
Clinical ApoA‐IV amyloid is associated with fibrillogenic signal sequence.
- Published in:
- Journal of Pathology, 2021, v. 255, n. 3, p. 311, doi. 10.1002/path.5770
- By:
- Publication type:
- Article
Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real‐world longitudinal data.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 587, doi. 10.1111/bjh.17636
- By:
- Publication type:
- Article
Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-91113-6
- By:
- Publication type:
- Article
Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 6, p. 1, doi. 10.1038/s41408-021-00510-7
- By:
- Publication type:
- Article
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 6, p. 2109, doi. 10.1007/s00415-019-09688-0
- By:
- Publication type:
- Article
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy.
- Published in:
- Neurology & Therapy, 2021, v. 10, n. 1, p. 375, doi. 10.1007/s40120-021-00235-6
- By:
- Publication type:
- Article
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases.
- Published in:
- European Heart Journal, 2021, v. 42, n. 16, p. 1554, doi. 10.1093/eurheartj/ehab072
- By:
- Publication type:
- Article
Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first‐line treatment of systemic light chain amyloidosis in the UK.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 537, doi. 10.1111/ejh.13582
- By:
- Publication type:
- Article
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 4, p. 512, doi. 10.1002/ejhf.2140
- By:
- Publication type:
- Article
Clinical Amyloid Typing by Proteomics: Performance Evaluation and Data Sharing between Two Centres.
- Published in:
- Molecules, 2021, v. 26, n. 7, p. 1913, doi. 10.3390/molecules26071913
- By:
- Publication type:
- Article
Renal transplant outcomes in amyloidosis.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 2, p. 355, doi. 10.1093/ndt/gfaa293
- By:
- Publication type:
- Article
Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage.
- Published in:
- ESC Heart Failure, 2020, v. 7, n. 6, p. 3942, doi. 10.1002/ehf2.12989
- By:
- Publication type:
- Article
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.
- Published in:
- BMC Family Practice, 2020, v. 21, n. 1, p. N.PAG, doi. 10.1186/s12875-020-01252-4
- By:
- Publication type:
- Article
The value of screening biopsies in light‐chain (AL) and transthyretin (ATTR) amyloidosis.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 3, p. 352, doi. 10.1111/ejh.13458
- By:
- Publication type:
- Article
Diagnostic amyloid proteomics: experience of the UK National Amyloidosis Centre.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2020, v. 58, n. 6, p. 948, doi. 10.1515/cclm-2019-1007
- By:
- Publication type:
- Article
Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light‐chain amyloidosis.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 4, p. 643, doi. 10.1111/bjh.16401
- By:
- Publication type:
- Article
The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 5, p. 638, doi. 10.1111/bjh.16122
- By:
- Publication type:
- Article
A 24‐year experience of autologous stem cell transplantation for light chain amyloidosis patients in the United Kingdom.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 5, p. 642, doi. 10.1111/bjh.16143
- By:
- Publication type:
- Article
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Plasma neurofilament light chain concentration is increased and correlates with the severity of neuropathy in hereditary transthyretin amyloidosis.
- Published in:
- Journal of the Peripheral Nervous System, 2019, v. 24, n. 4, p. 314, doi. 10.1111/jns.12350
- By:
- Publication type:
- Article